AZN vs WEX · P/E 28, $288.38B cap vs P/E 14, rev $1.43B
AstraZeneca PLC (AZN) versus Wex Inc (WEX) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Wex Inc (WEX) is a software - infrastructure company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported WEX revenue for 2026-06-30 was $1.43B. Net income was $186.2M. WEX currently screens at market cap $4.40B and trailing P/E 14.3.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. WEX currently screens at market cap $4.40B and trailing P/E 14.3.
Not investment advice. Open the AZN and WEX stock pages for the full models.
Not investment advice.